Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Biochem Pharmacol. 2021 Jun 7;196:114647. doi: 10.1016/j.bcp.2021.114647

Fig. 2.

Fig. 2.

Models for PTCH regulation of SMO. PTCH likely inhibits SMO by either removing an agonist from SMO (green arrows) or transferring an antagonist to SMO (red arrows). It is unclear whether the exchange between PTCH and SMO occurs between the extracellular domains (A) or transmembrane domains (B). The latter case implicates the existence of a sterol carrier protein that cooperates with PTCH (shown with a question mark).